Elevated Soluble fms-Like Tyrosine Kinase-1 Levels in Acute Coronary Occlusion
Author(s) -
Navin K. Kapur,
Kevin S. Heffernan,
Adil Yunis,
Tuan Anh Nguyen,
Mark Aronovitz,
Peter Parpos,
Szuhuei Wilson,
Corey Baker,
Michele Esposito,
Ameer T. Shah,
Carey Kimmelstiel,
Andrew Weintraub,
Richard H. Karas,
Michael E. Mendelsohn
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.215897
Subject(s) - coronary occlusion , medicine , tyrosine kinase , cardiology , soluble fms like tyrosine kinase 1 , chemistry , occlusion , receptor , vascular endothelial growth factor , placental growth factor , vegf receptors
Early recognition of an acute coronary occlusion (ACO) improves clinical outcomes. Soluble fms-like tyrosine kinase-1 (sFLT1) is an endothelium-derived protein induced by hypoxia. We tested whether sFLT1 levels are elevated in ACO.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom